Aster DM Healthcare Fixes Record Date for Amalgamation with Quality Care India Limited
Aster DM Healthcare Limited has set July 9, 2026, as the official Record Date to determine the entitlement of shareholders of Quality Care India Limited (QCIL) under their Scheme of Amalgamation. The decision was made following a Board meeting held on June 25, 2026, relating to the amalgamation with QCIL.The company confirmed that its Board took on record the order issued by the National Company Law Tribunal (NCLT), Hyderabad Bench, dated June 19, 2026, which approved the Scheme of Amalgamation between Aster DM Healthcare Limited and Quality Care India Limited.
In accordance with the terms outlined in the Scheme, the Board fixed July 9, 2026, as the Record Date. This date is intended to determine how equity shareholders of the Transferor Company (QCIL) will receive their fully paid-up equity shares of face value INR 10/- each in Aster DM Healthcare Limited, which acts as the Transferee Company.
The Scheme dictates a specific share exchange ratio: for every 1000 equity shares held in Quality Care India Limited, shareholders are entitled to 977 equity shares of Aster DM Healthcare Limited.
The Board meeting concerning the amalgamation commenced at 12:00 PM (IST) and concluded by 3:00 PM (IST).
ASTERDM Stock Price Movement
Shares of Aster DM Healthcare Limited slipped by 0.09% to settle at ₹769.05 on Thursday, closing marginally lower from its previous session. The equity experienced a range between a low of ₹765.4 and a high of ₹783.95 during the trading day, with total volume registering 381,419 shares.Disclaimer: Due care and diligence have been taken in compiling and presenting news and market-related content. However, errors or omissions may arise despite such efforts.
The information provided is for general informational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell any securities. Readers are advised to rely on their own assessment and judgment and consult appropriate financial advisers, if required, before taking any investment-related decisions.
Any views, opinions, or statements expressed, where applicable, are those of the respective analysts or experts and do not reflect the views of this website. The website has no association with such viewpoints and does not assume any responsibility for them.